1. Home
  2. ATNM vs JG Comparison

ATNM vs JG Comparison

Compare ATNM & JG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • JG
  • Stock Information
  • Founded
  • ATNM 2000
  • JG 2012
  • Country
  • ATNM United States
  • JG China
  • Employees
  • ATNM N/A
  • JG N/A
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • JG Computer Software: Programming Data Processing
  • Sector
  • ATNM Health Care
  • JG Technology
  • Exchange
  • ATNM Nasdaq
  • JG Nasdaq
  • Market Cap
  • ATNM 56.5M
  • JG 46.7M
  • IPO Year
  • ATNM N/A
  • JG 2018
  • Fundamental
  • Price
  • ATNM $1.17
  • JG $11.80
  • Analyst Decision
  • ATNM Strong Buy
  • JG Strong Buy
  • Analyst Count
  • ATNM 4
  • JG 1
  • Target Price
  • ATNM $8.75
  • JG $7.00
  • AVG Volume (30 Days)
  • ATNM 167.7K
  • JG 2.4M
  • Earning Date
  • ATNM 03-28-2025
  • JG 03-11-2025
  • Dividend Yield
  • ATNM N/A
  • JG N/A
  • EPS Growth
  • ATNM N/A
  • JG N/A
  • EPS
  • ATNM N/A
  • JG N/A
  • Revenue
  • ATNM $81,000.00
  • JG $42,829,425.00
  • Revenue This Year
  • ATNM $138.42
  • JG $77.44
  • Revenue Next Year
  • ATNM $16,957.05
  • JG N/A
  • P/E Ratio
  • ATNM N/A
  • JG N/A
  • Revenue Growth
  • ATNM N/A
  • JG 0.23
  • 52 Week Low
  • ATNM $1.07
  • JG $2.36
  • 52 Week High
  • ATNM $10.24
  • JG $20.94
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 46.97
  • JG 57.83
  • Support Level
  • ATNM $1.15
  • JG $10.76
  • Resistance Level
  • ATNM $1.29
  • JG $13.26
  • Average True Range (ATR)
  • ATNM 0.07
  • JG 2.02
  • MACD
  • ATNM 0.01
  • JG -0.05
  • Stochastic Oscillator
  • ATNM 46.51
  • JG 42.87

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, they gain access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.

Share on Social Networks: